Baidu
map

预防医学

订阅

MedSci主页 / 所有栏目 / 预防医学

Clinica Chimica Acta：超声造影在瘢痕妊娠误诊为其他疾病中的应用

2019-10-18 gladiator MedSci原创

瘢痕妊娠超声造影
关注

目的探讨超声造影(CEUS)对经阴道超声(TVS)误诊瘢痕妊娠的可行性。

目的探讨超声造影(CEUS)对经阴道超声(TVS)误诊瘢痕妊娠的可行性。

对3例临床怀疑有异常妊娠的患者行超声造影(CEUS)，TVS对其诊断不明确。分析本组病例的临床表现及特点。

子宫肌瘤切除术后壁内妊娠(IMP) 3例，剖宫产瘢痕妊娠(CSP) 2例，肿块分别由刮除术和自然流产引起。在所有这些病例中，植入处CEUS均可观察到早期高强度增强。此外，肿块内可见明显增强的信号，有或没有胚层周环。经有效治疗后，血块或肿块未见增强。

研究表明，超声造影可作为诊断瘢痕妊娠的辅助手段，并可评价治疗效果，尤其是在TVS检查结果不明确的情况下。

原始出处：

Dongmei Liu,Xiaoning Gu,Application of contrast-enhanced ultrasound for scar pregnancy cases misdiagnosed as other diseases

本文系梅斯医学（MedSci）原创编译整理，转载需授权！


版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1980390, encodeId=f987198039051, content=<a href='/topic/show?id=e89b928289a' target=_blank style='color:#2F92EE;'>#超声造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92828, encryptionId=e89b928289a, topicName=超声造影)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=jiangjun073, createdTime=Fri Jan 03 11:35:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998394, encodeId=582e19983942b, content=<a href='/topic/show?id=b3b1e122375' target=_blank style='color:#2F92EE;'>#瘢痕妊娠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71223, encryptionId=b3b1e122375, topicName=瘢痕妊娠)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c8c241, createdName=w363522449, createdTime=Thu Apr 02 21:35:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849783, encodeId=92ea1849e8326, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Fri Nov 22 02:35:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336982, encodeId=a335133698260, content=<a href='/topic/show?id=48f8e12220f' target=_blank style='color:#2F92EE;'>#瘢痕#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71222, encryptionId=48f8e12220f, topicName=瘢痕)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Sun Oct 20 11:35:00 CST 2019, time=2019-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494125, encodeId=20fe1494125f8, content=<a href='/topic/show?id=3e34949e333' target=_blank style='color:#2F92EE;'>#造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94973, encryptionId=3e34949e333, topicName=造影)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=908d9134595, createdName=sodoo, createdTime=Sun Oct 20 11:35:00 CST 2019, time=2019-10-20, status=1, ipAttribution=)]
    2020-01-03 jiangjun073

    #超声造影#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1980390, encodeId=f987198039051, content=<a href='/topic/show?id=e89b928289a' target=_blank style='color:#2F92EE;'>#超声造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92828, encryptionId=e89b928289a, topicName=超声造影)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=jiangjun073, createdTime=Fri Jan 03 11:35:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998394, encodeId=582e19983942b, content=<a href='/topic/show?id=b3b1e122375' target=_blank style='color:#2F92EE;'>#瘢痕妊娠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71223, encryptionId=b3b1e122375, topicName=瘢痕妊娠)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c8c241, createdName=w363522449, createdTime=Thu Apr 02 21:35:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849783, encodeId=92ea1849e8326, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Fri Nov 22 02:35:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336982, encodeId=a335133698260, content=<a href='/topic/show?id=48f8e12220f' target=_blank style='color:#2F92EE;'>#瘢痕#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71222, encryptionId=48f8e12220f, topicName=瘢痕)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Sun Oct 20 11:35:00 CST 2019, time=2019-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494125, encodeId=20fe1494125f8, content=<a href='/topic/show?id=3e34949e333' target=_blank style='color:#2F92EE;'>#造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94973, encryptionId=3e34949e333, topicName=造影)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=908d9134595, createdName=sodoo, createdTime=Sun Oct 20 11:35:00 CST 2019, time=2019-10-20, status=1, ipAttribution=)]
    2020-04-02 w363522449

    #瘢痕妊娠#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1980390, encodeId=f987198039051, content=<a href='/topic/show?id=e89b928289a' target=_blank style='color:#2F92EE;'>#超声造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92828, encryptionId=e89b928289a, topicName=超声造影)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=jiangjun073, createdTime=Fri Jan 03 11:35:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998394, encodeId=582e19983942b, content=<a href='/topic/show?id=b3b1e122375' target=_blank style='color:#2F92EE;'>#瘢痕妊娠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71223, encryptionId=b3b1e122375, topicName=瘢痕妊娠)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c8c241, createdName=w363522449, createdTime=Thu Apr 02 21:35:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849783, encodeId=92ea1849e8326, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Fri Nov 22 02:35:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336982, encodeId=a335133698260, content=<a href='/topic/show?id=48f8e12220f' target=_blank style='color:#2F92EE;'>#瘢痕#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71222, encryptionId=48f8e12220f, topicName=瘢痕)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Sun Oct 20 11:35:00 CST 2019, time=2019-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494125, encodeId=20fe1494125f8, content=<a href='/topic/show?id=3e34949e333' target=_blank style='color:#2F92EE;'>#造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94973, encryptionId=3e34949e333, topicName=造影)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=908d9134595, createdName=sodoo, createdTime=Sun Oct 20 11:35:00 CST 2019, time=2019-10-20, status=1, ipAttribution=)]
    2019-11-22 windight

    #CTA#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1980390, encodeId=f987198039051, content=<a href='/topic/show?id=e89b928289a' target=_blank style='color:#2F92EE;'>#超声造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92828, encryptionId=e89b928289a, topicName=超声造影)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=jiangjun073, createdTime=Fri Jan 03 11:35:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998394, encodeId=582e19983942b, content=<a href='/topic/show?id=b3b1e122375' target=_blank style='color:#2F92EE;'>#瘢痕妊娠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71223, encryptionId=b3b1e122375, topicName=瘢痕妊娠)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c8c241, createdName=w363522449, createdTime=Thu Apr 02 21:35:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849783, encodeId=92ea1849e8326, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Fri Nov 22 02:35:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336982, encodeId=a335133698260, content=<a href='/topic/show?id=48f8e12220f' target=_blank style='color:#2F92EE;'>#瘢痕#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71222, encryptionId=48f8e12220f, topicName=瘢痕)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Sun Oct 20 11:35:00 CST 2019, time=2019-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494125, encodeId=20fe1494125f8, content=<a href='/topic/show?id=3e34949e333' target=_blank style='color:#2F92EE;'>#造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94973, encryptionId=3e34949e333, topicName=造影)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=908d9134595, createdName=sodoo, createdTime=Sun Oct 20 11:35:00 CST 2019, time=2019-10-20, status=1, ipAttribution=)]
    2019-10-20 12498a1cm67暂无昵称

    #瘢痕#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1980390, encodeId=f987198039051, content=<a href='/topic/show?id=e89b928289a' target=_blank style='color:#2F92EE;'>#超声造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92828, encryptionId=e89b928289a, topicName=超声造影)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=jiangjun073, createdTime=Fri Jan 03 11:35:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998394, encodeId=582e19983942b, content=<a href='/topic/show?id=b3b1e122375' target=_blank style='color:#2F92EE;'>#瘢痕妊娠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71223, encryptionId=b3b1e122375, topicName=瘢痕妊娠)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c8c241, createdName=w363522449, createdTime=Thu Apr 02 21:35:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849783, encodeId=92ea1849e8326, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Fri Nov 22 02:35:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336982, encodeId=a335133698260, content=<a href='/topic/show?id=48f8e12220f' target=_blank style='color:#2F92EE;'>#瘢痕#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71222, encryptionId=48f8e12220f, topicName=瘢痕)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Sun Oct 20 11:35:00 CST 2019, time=2019-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494125, encodeId=20fe1494125f8, content=<a href='/topic/show?id=3e34949e333' target=_blank style='color:#2F92EE;'>#造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94973, encryptionId=3e34949e333, topicName=造影)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=908d9134595, createdName=sodoo, createdTime=Sun Oct 20 11:35:00 CST 2019, time=2019-10-20, status=1, ipAttribution=)]
    2019-10-20 sodoo

    #造影#

    0

相关资讯

2016剖宫产术后子宫瘢痕妊娠诊治专家共识发布

剖宫产术后子宫瘢痕妊娠（cesarean scar pregnancy, CSP）是指受精卵着床于前次剖宫产子宫切口瘢痕处的1种异位妊娠，是1个限时定义，仅限于早孕期（≤12周）；孕12周以后的中孕期CSP则诊断为“宫内中孕，剖宫产术后子宫瘢痕妊娠，胎盘植入”，如并发有胎盘前置，则诊断为“宫内中孕，剖宫产术后子宫瘢痕妊娠，胎盘植入，胎盘前置状态”，到了中晚孕期则为胎盘植入及前置胎盘，即形

Gynecol Obstet Invest：子宫动脉栓塞术（UAE）和氨甲喋呤（MTX）保守治疗剖宫产术后瘢痕妊娠的疗效比较

目的：剖腹产瘢痕妊娠（CSP）是一种罕见且严重的剖宫产术后并发症。CSP的发病率近年明显增加。这项回顾性研究中的131例被分为CSP患者宫动脉栓塞组与全身甲氨蝶呤组，比较两组的治疗效果及预后情况。此外，必要的后续扩张和刮除作为一个进一步的治疗手段被进行了评价。方法：131例患者随机分为两组接受子宫动脉栓塞术（UAE）或MTX保守治疗。决定患者接受后续的扩张和刮除术，是基于患者的子宫肌层厚度和β-H

Baidu
map
Baidu
map
Baidu
map